Anemia is a common complication of myelosuppressive chemotherapy that results in a
decreased functional capacity and quality of life (QOL) for cancer patients. Severe anemia is …

Anemia is common in patients with cancer. This systematic literature review of reports
published in 1966 through February 2003 identified the prevalence of anemia in specific …

Background Single-agent ibrutinib has shown substantial activity in patients with relapsed
Waldenström's macroglobulinemia, a rare form of B-cell lymphoma. We evaluated the effect …

Background Lung metastasectomy in the treatment of advanced colorectal cancer has been
widely adopted without good evidence of survival or palliative benefit. We aimed to test its …

What is the little button for? This button is pushed at bedtime and awake time to let the
research know what time you went to bed and got up. This button can also be used with the …

Abstract BACKGROUND The Pediatric Quality of Life Inventory (PedsQL) is a modular
instrument designed to measure health‐related quality of life (HRQOL) in children and …

The myelodysplastic syndromes (MDSs) are heterogeneous with respect to clinical
characteristics, pathologic features, and cytogenetic abnormalities. This heterogeneity is a …

Importance Financial toxicity (FT), unintended and unanticipated financial burden
experienced by cancer patients undergoing cancer care, is associated with negative …

Background In the era of widespread rituximab use for Waldenström's macroglobulinaemia,
new treatment options for patients with rituximab-refractory disease are an important clinical …

BACKGROUND Although fatigue is a common symptom among cancer patients, it is also a
common experience in the general, healthy population. Its universality has made it difficult to …